Ruxolitinib Delays Nucleus Pulposus Cell Senescence in Rat Intervertebral Discs.

Honggang Hao, Weidong Liang, Shuwen Zhang, Xiaoyu Cai, Abulizi Yakefu, Shutao Gao, Chuanhui Xun, Tao Xu, Rui Cao, Weibin Sheng

Department of Spine Surgery The First Affiliated Hospital of Xinjiang Medical University Urumqi China.Department of Spine Surgery The First Affiliated Hospital of Xinjiang Medical University Urumqi China. · pubmed

Paper

Abstract

Intervertebral disc degeneration involves aging and senescence of nucleus pulposus cells (NPCs), and JAK/STAT signaling may contribute to this process. The aim of this study was to investigate the therapeutic effect of the JAK2 inhibitor, ruxolitinib, on NPC senescence.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that ruxolitinib can delay the senescence of nucleus pulposus cells in intervertebral discs. This research is relevant as it explores a potential therapeutic approach to address cellular senescence, which is a key factor in the aging process and age-related degeneration.

Author of this paper? Send a correction.